Reduction of Stromatinia cepivora inocula and control of white rot disease in onion and garlic crops by repeated soil applications with sclerotial germination stimulants

The effect of soil-applied Allium crop products on the Stromatinia cepivora viability and the incidence of white rot in subsequent onion and garlic crops were evaluated in this work. The tested products were onion powder, garlic powder, onion oil, garlic oil and Allium waste (onion and garlic) that are described as sclerotial germination stimulants. Under in vitro conditions, data revealed that more than 80% of the sclerotia died in the soil treated with sclerotial germination stimulants. Under greenhouse conditions, soil-artificially infested with sclerotia of S. cepivora and treated with sclerotial germination stimulants for 6-months before cultivation, significantly reduced the incidence of white rot on onion and garlic. Onion oil, garlic oil and Allium waste were the most effective treatments, decreasing disease incidence by 78.6% in onion and 80.0% in garlic. Under field conditions, sclerotial germination stimulants were incorporated into the soil in commercial fields naturally infested with S. cepivora. Two fields were chosen based on differential sclerotial density. Within 6 months after treatment, more than 70% of the sclerotia died in the plots treated with sclerotial germination stimulants. In subsequent onion and garlic crops planted approximately one year after soil treatment, sclerotial germination stimulants were more effective than the control in reducing white rot symptoms coupled with low inoculum density (45.9 sclerotia/kg of soil). Reduction of white rot disease was accompanied by increased of growth and bulbs yield of onion and garlic plants. Despite the efficacy of sclerotial germination stimulants to reduce populations of viable sclerotia in soil with a high inoculum density (594.7 sclerotia/kg of soil), the pathogen caused substantial white rot and yield losses in subsequent onion and garlic crops planted approximately one year after soil treatment

Effect of Maturity Stage on Cereal and Leguminous Seeds’ Metabolome as Analyzed Using Gas Chromatography Mass-Spectrometry (GC-MS) and Chemometric Tools

Cereal and leguminous seeds are considered as major generic dietary source of energy, carbohydrates as well as proteins in the Mediterranean diet and are frequently consumed in their immature form in several regions including the Middle East. Hence, the current study aimed to assess metabolites’ heterogeneity amongst five major cereal and leguminous seeds of different species, and cultivars, i.e., Triticum aestivum L. (two cultivars), Hordeum vulgare L., Vicia faba L. and Cicer arietinum L., at different maturity stages. Gas chromatography mass-spectrometry (GC-MS) analysis using multivariate data analyses was employed for nutrient profiling and sample segregation assessed using chemometric tools, respectively. A total of 70 peaks belonging to sugars, fatty acids/esters, steroids, amino acids and organic acids were identified including sucrose, melibiose, glucose and fructose as major sugars, with butyl caprylate, hydroxybutanoic acid and malic acid contributing to the discrimination between seed species at different maturity stages. The investigation of total protein content revealed comparable protein levels amongst all examined seeds with the highest level detected at 20.1% w/w in mature fava bean. Results of this study provide a novel insight on cereal and leguminous seeds’ metabolomics in the context of their maturity stages for the first time in literature

Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, in-vitro, in silico, and in-vivo study

AbstractCanagliflozin (CFZ) is a sodium-glucose cotransporter-2 inhibitor (SGLT2) that lowers albuminuria in type-2 diabetic patients, cardiovascular, kidney, and liver disease. CFZ is classified as class IV in the Biopharmaceutical Classification System (BCS) and is characterized by low permeability, solubility, and bioavailability, most likely attributed to hepatic first-pass metabolism. Nanocrystal-based sublingual formulations were developed in the presence of sodium caprate, as a wetting agent, and as a permeability enhancer. This formulation is suitable for children and adults and could enhance solubility, permeability, and avoid enterohepatic circulation due to absorption through the sublingual mucosa. In the present study, formulations containing various surfactants (P237, P338, PVA, and PVP K30) were prepared by the Sono-homo-assisted precipitation ion technique. The optimized formula prepared with PVP-K30 showed the smallest particle size (157 ± 0.32 nm), Zeta-potential (−18 ± 0.01), and morphology by TEM analysis. The optimized formula was subsequently formulated into a sublingual tablet containing Pharma burst-V® with a shorter disintegration time (51s) for the in-vivo study. The selected sublingual tablet improved histological and biochemical markers (blood glucose, liver, and kidney function), AMP-activated protein kinase (AMPK), and protein kinase B (AKT) pathway compared to the market formula, increased CFZ’s antidiabetic potency in diabetic rabbits, boosted bioavailability by five-fold, and produced faster onset of action. These findings suggest successful treatment of diabetes with CFZ nanocrystal-sublingual tablets

Global economic burden of unmet surgical need for appendicitis

Background There is a substantial gap in provision of adequate surgical care in many low- and middle-income countries. This study aimed to identify the economic burden of unmet surgical need for the common condition of appendicitis. Methods Data on the incidence of appendicitis from 170 countries and two different approaches were used to estimate numbers of patients who do not receive surgery: as a fixed proportion of the total unmet surgical need per country (approach 1); and based on country income status (approach 2). Indirect costs with current levels of access and local quality, and those if quality were at the standards of high-income countries, were estimated. A human capital approach was applied, focusing on the economic burden resulting from premature death and absenteeism. Results Excess mortality was 4185 per 100 000 cases of appendicitis using approach 1 and 3448 per 100 000 using approach 2. The economic burden of continuing current levels of access and local quality was US $92 492 million using approach 1 and$73 141 million using approach 2. The economic burden of not providing surgical care to the standards of high-income countries was $95 004 million using approach 1 and$75 666 million using approach 2. The largest share of these costs resulted from premature death (97.7 per cent) and lack of access (97.0 per cent) in contrast to lack of quality. Conclusion For a comparatively non-complex emergency condition such as appendicitis, increasing access to care should be prioritized. Although improving quality of care should not be neglected, increasing provision of care at current standards could reduce societal costs substantially

Global economic burden of unmet surgical need for appendicitis

Background There is a substantial gap in provision of adequate surgical care in many low- and middle-income countries. This study aimed to identify the economic burden of unmet surgical need for the common condition of appendicitis. Methods Data on the incidence of appendicitis from 170 countries and two different approaches were used to estimate numbers of patients who do not receive surgery: as a fixed proportion of the total unmet surgical need per country (approach 1); and based on country income status (approach 2). Indirect costs with current levels of access and local quality, and those if quality were at the standards of high-income countries, were estimated. A human capital approach was applied, focusing on the economic burden resulting from premature death and absenteeism. Results Excess mortality was 4185 per 100 000 cases of appendicitis using approach 1 and 3448 per 100 000 using approach 2. The economic burden of continuing current levels of access and local quality was US $92 492 million using approach 1 and$73 141 million using approach 2. The economic burden of not providing surgical care to the standards of high-income countries was $95 004 million using approach 1 and$75 666 million using approach 2. The largest share of these costs resulted from premature death (97.7 per cent) and lack of access (97.0 per cent) in contrast to lack of quality. Conclusion For a comparatively non-complex emergency condition such as appendicitis, increasing access to care should be prioritized. Although improving quality of care should not be neglected, increasing provision of care at current standards could reduce societal costs substantially